New drug shows promise for kidney disease in early trial
NCT ID NCT03945318
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a new drug called BION-1301 in 103 healthy volunteers and adults with IgA nephropathy, a kidney disease. The main goal was to check the drug's safety and how the body processes it. Researchers measured side effects, blood pressure, and kidney function over time.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IGA NEPHROPATHY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Amicis Research Center
Northridge, California, 91324, United States
-
Chris Sholer, P.C.
Oklahoma City, Oklahoma, 73116, United States
-
Colorado Kidney Care, P.C.
Denver, Colorado, 80230, United States
-
Elixia Tampa, LLC
Tampa, Florida, 33618, United States
-
Hallym University Sacred Heart Hospital
Anyang-si, Gyeonggi-do, 14068, South Korea
-
Hanyang University Guri Hostpital
Guri-si, Gyeonggi-do, 11923, South Korea
-
Liberty Research Center
Arlington, Texas, 76012, United States
-
Liberty Research Center
Dallas, Texas, 75230, United States
-
Liverpool University Hospital NHS Foundation Trust
Liverpool, England, L7 8XP, United Kingdom
-
National Health Insurance Service Ilsan Hospital
Goyang-si, Gyeonggi-do, 10444, South Korea
-
Nephrology Associates of Central Florida
Orlando, Florida, 32806, United States
-
New York Nephrology
Clifton Park, New York, 12065, United States
-
PAREXEL Early Phase Clinical Unit
London, HA1 3UJ, United Kingdom
-
Prolato Clinical Research Center
Houston, Texas, 77054, United States
-
Seoul National University Bundang Hospital
Seongnam-si, Gyeonggi-do, 13620, South Korea
-
Soon Chun Hyang University Hospital Cheonan
Cheonan, Chungcheongnam-do, 31151, South Korea
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Mapping the Real-World treatment landscape for IgA nephropathy
- A simple test could forecast kidney disease progression
- Experimental drug aims to protect kidneys in inflammatory diseases
- Scientists probe kidney cell metabolism to unlock secrets of ANCA vasculitis
- Immune cell therapy takes on kidney disease
- Steroids for kidney disease: do they prevent failure Long-Term?